(Q39696841)
Statements
1 reference
Anti-platelet effects of long-term treatment with gliclazide in diabetic patients (English)
O. Ponari
E. Civardi
S. Megha
M. Pini
D. Portioli
1 January 1979
1 reference
1 reference
8
845
Platelet adhesiveness in diabetes mellitus (English)
Shaw
1967
6
436
Platelet adhesiveness, plasma fibrinogen and factor VIII level in diabetes mellitus (English)
Mayne
1970
30
195
Enhanced platelet aggregation as a risk factor for vascular disease and its thromboembolic complications (English)
Breddin
1975
82
733
Increased platelet aggregation in early diabetes mellitus (English)
Sagel
1975
9
467
In vivo platelet function in diabetes mellitus (English)
Fleischman
1976
19
698
Platelet phospholipid and their function in patients with juvenile diabetes and maturity-onset diabetes (English)
Nordoy
1970
0 references
7
308
Platelet adhesiveness and aggregation in relation to diabetic retinopathy (English)
Heath
1971
2
1274
Platelet abnormalities in diabetic peripheral neuropathy (English)
O'Malley
1975
91
107
Role of platelets in pathogenesis of diabetic retinopathy (English)
Dobbie
1974
6
345
Effects of gliclazide, a new antidiabetic agent on the platelet release reaction; role of adenylate cyciase (English)
Lagarde
1975
4
538
Effects “in vitro” du gliclazide, nouvel agent hypoglycemiant, sur les plaquettes humaines normales (English)
Vainer
1974
Identifiers
1 reference